ITN TREATMENT was granted the status of a WHO (World Health Organization) Collaborating Centre for Research. All members of the Consortium of ITN TREATMENT put the focus on drug induced metabolic dysfunctions.The project is coordinated by María Monsalve and Ángela Valverde from the IIBM (CSIC-UAM) in Madrid, Spain.